NCT03445169View on ClinicalTrials.gov

A Food Effect Study in Healthy Volunteers With Belzutifan (PT2977, MK-6482) Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 23, 2018

Primary Completion Date

May 26, 2018

Study Completion Date

May 26, 2018

Conditions
Healthy
Interventions
DRUG

Belzutifan

Belzutifan Tablets

Trial Locations (1)

53095

Spaulding Clinical, West Bend

All Listed Sponsors
lead

Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY

NCT03445169 - A Food Effect Study in Healthy Volunteers With Belzutifan (PT2977, MK-6482) Tablets | Biotech Hunter | Biotech Hunter